Boston, MA, United States
The General Hospital Corporation recalls
1 recall recorded since 2018, most recently on 17 February 2021. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 17 February 2021
- Terminated
- 26 March 2021
- Reason
- Lack of Assurance of Sterility
- Distribution
- Product was distributed to one direct account.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0288-2021
- Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.